NCT05253963

Brief Summary

The effect of CPAP on weight and fluid homeostasis will be assessed. Obstructive sleep apnea treatment-naive subjects will randomized to CPAP and control groups. Weight change, and changes in overnight urinary volume, intra and extracelullar volume, plasmatic B-type natriuretic peptide (BNP) and antidiuretic hormone (ADH) and urinary osmolality will be compared between groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

September 29, 2021

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 24, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2022

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

1.2 years

First QC Date

September 29, 2021

Last Update Submit

May 8, 2024

Conditions

Keywords

Obstructive Sleep ApneaContinuous Positive Airway PressureWeight Gain

Outcome Measures

Primary Outcomes (2)

  • Weight change

    Weight change with just one night of CPAP treatment.

    After 6 hours of Continuous Positive Airway Pressure treatment

  • Diuresis change

    diuresis change with just one night of CPAP treatment.

    After 6 hours of Continuous Positive Airway Pressure treatment

Secondary Outcomes (3)

  • Urinary osmolarity

    After 10 hours of the nocturnal polysomnography

  • Atrial natriuretic peptide and antidiuretic hormone

    After 10 hours of the nocturnal polysomnography

  • Intra and extracellular fluid volume

    Before the beginning and after 10 hours of the nocturnal polysomnography.

Study Arms (2)

Control

NO INTERVENTION

During the first and second study nights, subjects will undergo baseline polysomnography.

Continuous Positive Airway Pressure

EXPERIMENTAL

Baseline polysomnography will be perfomed during the first study night and CPAP titration polysomnography will be performed during the second study night.

Device: Continuous Positive Airway Pressure

Interventions

Continuous Positive Airway Pressure will be used during the second night of polysomnography .

Continuous Positive Airway Pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a diagnosis of Obstructive Apnea Sleep
  • Over 18 years of age
  • No previous treatment with Continuous Positive Airway Pressure

You may not qualify if:

  • Congestive heart failure
  • Renal insufficiency
  • Hepatic failure
  • Urinary incontinency
  • Diuretic therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep Laboratory, Heart Institute, Pulmonary Division, Hospital das Clínicas da Universidade de São Paulo

São Paulo, 55, Brazil

Location

Related Publications (1)

  • Lima GF, Herculano S, Fernandes MD, Lima-Junior JGA, Alves RSC, Drager LF, Lorenzi-Filho G, Genta PR. Acute Effect of Continuous Positive Airway Pressure (CPAP) on Weight in Patients with Obstructive Sleep Apnea: A Randomized Study. Ann Am Thorac Soc. 2025 Sep 30. doi: 10.1513/AnnalsATS.202505-491OC. Online ahead of print.

MeSH Terms

Conditions

Sleep Apnea, ObstructiveWeight Gain

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Pedro R Genta, MD.PhD

    Sleep Laboratoy, Heart Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 29, 2021

First Posted

February 24, 2022

Study Start

September 29, 2021

Primary Completion

November 29, 2022

Study Completion

November 29, 2022

Last Updated

May 9, 2024

Record last verified: 2024-05

Locations